Evaluation of Four Semi‐Mechanistic Models for Predicting Glycemic Control With a Glucagon Receptor Antagonist in People With Type 2 Diabetes
ABSTRACT Glycated hemoglobin (HbA1c) is the gold standard for measuring long‐term glycemic efficacy over at least 3 months in Type 2 diabetes (T2D). Being able to predict HbA1c using glucose response from studies of less than 3 months would be useful. Four semi‐mechanistic HbA1c models (ADOPT, FFH,...
Saved in:
| Main Authors: | Austin Yue Feng Tan, Karen Schneck, Parag Garhyan, Eric Chun Yong Chan, Lai San Tham |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | CPT: Pharmacometrics & Systems Pharmacology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/psp4.70058 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Zinc Supplementation on Glycemic Control in Patients with Type 1 Diabetes
by: Peyman Payami, et al.
Published: (2013-04-01) -
Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis
by: Mohammad Amin Karimi, et al.
Published: (2025-05-01) -
Cross‐sectional association of irregular dietary habits with glycemic control and body mass index among people with diabetes
by: Mika Shimizu, et al.
Published: (2025-02-01) -
Characteristics of insulin prescriptions and their association with glycemic control in adults with type 2 diabetes mellitus
by: Helen Chen, et al.
Published: (2025-07-01) -
Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control
by: Seung Hee Lee, et al.
Published: (2025-07-01)